Veterans are traveling to Mexico to Get Ibogaine for PTSD, now Trump Plans to Order Study on Psychedelic Drug
President Donald Trump is expected to sign an executive order in the next days aimed at expanding U.S. research into ibogaine, a psychedelic compound that some clinics abroad use to treat post-traumatic stress disorder, traumatic brain injury, addiction, depression and anxiety, according to CBS News.
Latin Times ·